Helix BioMedix, Inc. (HXBM)
USD 12.0
(20.0%)
USD 12.0
(20.0%)
| Breakdown | 2023 | 2022 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -870.2 Thousand | -727.73 Thousand | -2.29 Million | -2.79 Million | -3.07 Million | -3.14 Million |
| Net Income | -1.05 Million | -1.19 Million | -2.48 Million | -7.71 Million | -3.77 Million | -4.51 Million |
| Depreciation & Amortization | 9745.00 | 12.72 Thousand | 109.17 Thousand | 113.77 Thousand | 130.59 Thousand | 133.75 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -106.26 Thousand | -788.00 | -154.08 Thousand | -131.47 Thousand | -95.87 Thousand | -107 Thousand |
| Other non-cash items | 318.64 Thousand | 374.02 Thousand | 699.2 Thousand | 5.4 Million | 1.03 Million | 1.65 Million |
| Investing Cash Flow | 6251.00 | 1.24 Million | -59.32 Thousand | -355.3 Thousand | 927.44 Thousand | -299.52 Thousand |
| Investments in PPE | -1318.00 | -1345.00 | -2669.00 | -5305.00 | -42.55 Thousand | -29.52 Thousand |
| Acquisitions | 7569.00 | - | 6000.00 | - | - | - |
| Investment purchases | - | - | -42 Thousand | -350 Thousand | - | - |
| Sales/Maturities of investments | - | 1.24 Million | - | - | - | 700 Thousand |
| Other Investing Activities | - | - | -20.65 Thousand | - | 970 Thousand | -970 Thousand |
| Financing Cash Flow | - | - | - | 5.85 Million | 2.5 Million | 3.96 Million |
| Debt repayment | - | - | - | -3.1 Million | -2.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 2.75 Million | - | 3.96 Million |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -56.37 Thousand | 119.67 Thousand | -152.76 Thousand | -232.25 Thousand | -5218.00 | 33.44 Thousand |
| Accounts payables | 39.59 Thousand | -19.44 Thousand | -5165.00 | 64.03 Thousand | -5369.00 | -23.24 Thousand |
| Inventory | - | 3684.00 | -85.47 Thousand | -75.57 Thousand | -91.4 Thousand | -46.13 Thousand |
| Other working capital | -89.48 Thousand | -104.7 Thousand | 89.31 Thousand | 112.33 Thousand | 6116.00 | -71.07 Thousand |
| Cash at beginning of period | 3.43 Million | 1.68 Million | 4.04 Million | 1.34 Million | 970 Thousand | 461.29 Thousand |
| Cash at end of period | 2.57 Million | 3.43 Million | 1.68 Million | 4.04 Million | 1.34 Million | 970 Thousand |
| Capital Expenditure | -1318.00 | -1345.00 | -2669.00 | -5305.00 | -42.55 Thousand | -29.52 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -863.95 Thousand | 1.74 Million | -2.35 Million | 2.69 Million | 374.71 Thousand | 508.71 Thousand |
| Free Cash Flow | -871.52 Thousand | -729.07 Thousand | -2.29 Million | -2.8 Million | -3.11 Million | -3.17 Million |
| Breakdown | 2023 FY | 2022 FY | 2011 FY | 2010 FY | 2009 FY | 2008 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.05 Million | -1.19 Million | -2.48 Million | -7.71 Million | -3.77 Million | -4.51 Million |
| Depreciation & Amortization | 9745.00 | 12.72 Thousand | 109.17 Thousand | 113.77 Thousand | 130.59 Thousand | 133.75 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -106.26 Thousand | -788.00 | -154.08 Thousand | -131.47 Thousand | -95.87 Thousand | -107 Thousand |
| Other non-cash items | 318.64 Thousand | 374.02 Thousand | 699.2 Thousand | 5.4 Million | 1.03 Million | 1.65 Million |
| Investing Cash Flow | 6251.00 | 1.24 Million | -59.32 Thousand | -355.3 Thousand | 927.44 Thousand | -299.52 Thousand |
| Investments in PPE | -1318.00 | -1345.00 | -2669.00 | -5305.00 | -42.55 Thousand | -29.52 Thousand |
| Acquisitions | 7569.00 | - | 6000.00 | - | - | - |
| Investment purchases | - | - | -42 Thousand | -350 Thousand | - | - |
| Sales/Maturities of investments | - | 1.24 Million | - | - | - | 700 Thousand |
| Other Investing Activities | - | - | -20.65 Thousand | - | 970 Thousand | -970 Thousand |
| Financing Cash Flow | - | - | - | 5.85 Million | 2.5 Million | 3.96 Million |
| Debt repayment | - | - | - | -3.1 Million | -2.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 2.75 Million | - | 3.96 Million |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -56.37 Thousand | 119.67 Thousand | -152.76 Thousand | -232.25 Thousand | -5218.00 | 33.44 Thousand |
| Accounts payables | 39.59 Thousand | -19.44 Thousand | -5165.00 | 64.03 Thousand | -5369.00 | -23.24 Thousand |
| Inventory | - | 3684.00 | -85.47 Thousand | -75.57 Thousand | -91.4 Thousand | -46.13 Thousand |
| Other working capital | -89.48 Thousand | -104.7 Thousand | 89.31 Thousand | 112.33 Thousand | 6116.00 | -71.07 Thousand |
| Cash at beginning of period | 3.43 Million | 1.68 Million | 4.04 Million | 1.34 Million | 970 Thousand | 461.29 Thousand |
| Cash at end of period | 2.57 Million | 3.43 Million | 1.68 Million | 4.04 Million | 1.34 Million | 970 Thousand |
| Capital Expenditure | -1318.00 | -1345.00 | -2669.00 | -5305.00 | -42.55 Thousand | -29.52 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -863.95 Thousand | 1.74 Million | -2.35 Million | 2.69 Million | 374.71 Thousand | 508.71 Thousand |
| Free Cash Flow | -871.52 Thousand | -729.07 Thousand | -2.29 Million | -2.8 Million | -3.11 Million | -3.17 Million |
YAARI
688356
ESTAR
WRKS
JOMA
KMSTF